IBDEI2O0 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44723,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,44723,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,44723,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,44724,0)
 ;;=N41.9^^200^2230^38
 ;;^UTILITY(U,$J,358.3,44724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44724,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,44724,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,44724,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,44725,0)
 ;;=N70.91^^200^2230^75
 ;;^UTILITY(U,$J,358.3,44725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44725,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,44725,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,44725,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,44726,0)
 ;;=N70.93^^200^2230^74
 ;;^UTILITY(U,$J,358.3,44726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44726,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,44726,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,44726,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,44727,0)
 ;;=N70.92^^200^2230^55
 ;;^UTILITY(U,$J,358.3,44727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44727,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,44727,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,44727,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,44728,0)
 ;;=N73.9^^200^2230^37
 ;;^UTILITY(U,$J,358.3,44728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44728,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,44728,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,44728,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,44729,0)
 ;;=A56.11^^200^2230^36
 ;;^UTILITY(U,$J,358.3,44729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44729,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,44729,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,44729,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,44730,0)
 ;;=N73.5^^200^2230^64
 ;;^UTILITY(U,$J,358.3,44730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44730,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,44730,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,44730,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,44731,0)
 ;;=N72.^^200^2230^35
 ;;^UTILITY(U,$J,358.3,44731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44731,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,44731,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,44731,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,44732,0)
 ;;=N76.3^^200^2230^92
 ;;^UTILITY(U,$J,358.3,44732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44732,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,44732,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,44732,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,44733,0)
 ;;=N76.1^^200^2230^88
 ;;^UTILITY(U,$J,358.3,44733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44733,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,44733,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,44733,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,44734,0)
 ;;=N76.2^^200^2230^91
 ;;^UTILITY(U,$J,358.3,44734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44734,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,44734,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,44734,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,44735,0)
 ;;=N76.0^^200^2230^87
 ;;^UTILITY(U,$J,358.3,44735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44735,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,44735,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,44735,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,44736,0)
 ;;=M00.20^^200^2230^3
 ;;^UTILITY(U,$J,358.3,44736,1,0)
 ;;=^358.31IA^4^2
